Formal Modeling of the Key Determinants of Hepatitis C Virus (HCV) Induced Adaptive Immune Response Network: An Integrative Approach to Map the Cellular and Cytokine-Mediated Host Immune Regulations
暂无分享,去创建一个
Jamil Ahmad | Amjad Ali | Ayesha Obaid | Anam Naz | Shifa Tariq Ashraf | Faryal Mehwish Awan | Aqsa Ikram | Muhammad Tariq Saeed | Abida Raza | Ayesha Obaid | Amjad Ali | A. Naz | F. M. Awan | J. Ahmad | A. Ikram | M. T. Saeed | S. Ashraf | Abida Raza
[1] A. Paiva,et al. Differences in Hepatitis C Virus (HCV)-Specific CD8 T-Cell Phenotype during Pegylated Alpha Interferon and Ribavirin Treatment Are Related to Response to Antiviral Therapy in Patients Chronically Infected with HCV , 2008, Journal of Virology.
[2] Aamir Shafi,et al. Formal modeling and analysis of the hexosamine biosynthetic pathway: role of O-linked N-acetylglucosamine transferase in oncogenesis and cancer progression , 2016, PeerJ.
[3] M. Hassany,et al. How to optimize HCV therapy in genotype 4 patients , 2013, Liver international : official journal of the International Association for the Study of the Liver.
[4] J. Ritz,et al. Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT4. , 2000, Blood.
[5] Carlo Ferrari,et al. Activation of natural killer cells during acute infection with hepatitis C virus. , 2010, Gastroenterology.
[6] T. Liang,et al. Hepatitis C virus–like particles induce virus‐specific humoral and cellular immune responses in mice , 2001, Hepatology.
[7] Y. Imai,et al. Restoration of natural killer cell activity by pegylated interferon‐alpha/ribavirin therapy in chronic hepatitis C patient , 2015, Hepatology research : the official journal of the Japan Society of Hepatology.
[8] Lisa-Ann Marie Gillings. Light at the End of the Tunnel , 2016 .
[9] C. Leonetti,et al. Cell communication and signaling: how to turn bad language into positive one , 2019, Journal of Experimental & Clinical Cancer Research.
[10] M. Levrero,et al. Mechanism of action of ribavirin in anti-HCV regimens: new insights for an age-old question? , 2013, Gut.
[11] T. Liang,et al. Ribavirin improves the IFN‐γ response of natural killer cells to IFN‐based therapy of hepatitis C virus infection , 2014, Hepatology.
[12] J. Baumbach,et al. Modeling and analysis of innate immune responses induced by the host cells against hepatitis C virus infection. , 2015, Integrative biology : quantitative biosciences from nano to macro.
[13] H. Wedemeyer,et al. Treating viral hepatitis C: efficacy, side effects, and complications , 2006, Gut.
[14] Luay Nakhleh,et al. The Signaling Petri Net-Based Simulator: A Non-Parametric Strategy for Characterizing the Dynamics of Cell-Specific Signaling Networks , 2008, PLoS Comput. Biol..
[15] S. Klamt,et al. Modeling approaches for qualitative and semi-quantitative analysis of cellular signaling networks , 2013, Cell Communication and Signaling.
[16] Ralf Bartenschlager,et al. The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection , 2013, Nature Reviews Microbiology.
[17] K. Mills,et al. Hepatitis C virus non‐structural protein 4 suppresses Th1 responses by stimulating IL‐10 production from monocytes , 2003, European journal of immunology.
[18] J. Roujeau,et al. Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals. , 2012, Journal of hepatology.
[19] D Thieffry,et al. GINsim: a software suite for the qualitative modelling, simulation and analysis of regulatory networks. , 2006, Bio Systems.
[20] R. Carithers,et al. A multicenter study of recombinant human interleukin 12 for the treatment of chronic hepatitis C virus infection in patients nonresponsive to previous therapy , 2003, Hepatology.
[21] H. Rosen. Emerging concepts in immunity to hepatitis C virus infection. , 2013, The Journal of clinical investigation.
[22] Thomas K. Hazlet,et al. Global Epidemiology of Hepatitis B Virus , 2004, Journal of clinical gastroenterology.
[23] C. Walker,et al. Adaptive immune responses in acute and chronic hepatitis C virus infection , 2005, Nature.
[24] Tom C Freeman,et al. Petri Net computational modelling of Langerhans cell Interferon Regulatory Factor Network predicts their role in T cell activation , 2017, Scientific Reports.
[25] Francesco Pappalardo,et al. Mathematical modeling of biological systems , 2013, Briefings Bioinform..
[26] C. Tseng,et al. Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions , 2002, The Journal of experimental medicine.
[27] M. Caligiuri,et al. Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.
[28] Assieh Saadatpour,et al. A Reduction Method for Boolean Network Models Proven to Conserve Attractors , 2013, SIAM J. Appl. Dyn. Syst..
[29] Wolfgang Reisig,et al. Application and Theory of Petri Nets , 1982, Informatik-Fachberichte.
[30] J. Bohlius,et al. Current Opinion in HIV and AIDS , 2016 .
[31] M. Heim,et al. Innate and adaptive immune responses in HCV infections. , 2014, Journal of hepatology.
[32] J. Gill,et al. Immunobiology of hepatitis C virus (HCV) infection: the role of CD4 T cells in HCV infection , 2000, Immunological reviews.
[33] A. Gattoni,et al. Interferon-gamma: biologic functions and HCV terapy (type I/II) (2 of 2 parts). , 2006, La Clinica terapeutica.
[34] Barbara Rehermann,et al. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. , 2009, The Journal of clinical investigation.
[35] Adrien Richard,et al. Application of formal methods to biological regulatory networks: extending Thomas' asynchronous logical approach with temporal logic. , 2004, Journal of theoretical biology.
[36] A. Kim. Hepatitis C Virus , 2016, Annals of Internal Medicine.
[37] Jincun Zhao,et al. Differential Effects of IL-12 on Tregs and Non-Treg T Cells: Roles of IFN-γ, IL-2 and IL-2R , 2012, PloS one.
[38] T. Berg,et al. Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection. , 2003, Hepato-gastroenterology.
[39] C. Perno,et al. Resistance to direct-acting antiviral agents: clinical utility and significance , 2015, Current opinion in HIV and AIDS.
[40] Darius Moradpour,et al. Replication of hepatitis C virus , 2007, Nature Reviews Microbiology.
[41] M. Binder,et al. Failure of innate and adaptive immune responses in controlling hepatitis C virus infection. , 2012, FEMS microbiology reviews.
[42] Daniel Grant Pellicci. The molecular and structural basis for antigen recognition by NKT cells , 2012 .
[43] G. Trinchieri,et al. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. , 1998, Journal of immunology.
[44] E. Brambilla,et al. Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis. , 2010, Journal of hepatology.
[45] Aurélien Naldi,et al. A Reduction of Logical Regulatory Graphs Preserving Essential Dynamical Properties , 2009, CMSB.
[46] J. Orange,et al. Natural killer cells inhibit hepatitis C virus expression , 2004, Journal of leukocyte biology.
[47] Deborah Chavez,et al. Antiviral Effect and Virus-Host Interactions in Response to Alpha Interferon, Gamma Interferon, Poly(I)-Poly(C), Tumor Necrosis Factor Alpha, and Ribavirin in Hepatitis C Virus Subgenomic Replicons , 2003, Journal of Virology.
[48] Céline Hernandez,et al. Hepatitis C Virus (HCV) Evades NKG2D-Dependent NK Cell Responses through NS5A-Mediated Imbalance of Inflammatory Cytokines , 2010, PLoS pathogens.
[49] Yasmine Belkaid,et al. Natural regulatory T cells in infectious disease , 2005, Nature Immunology.
[50] R. Bartenschlager,et al. Interferon‐γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs , 2002 .
[51] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[52] J. Woodgett,et al. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. , 2006, Immunity.
[53] Didier Lime,et al. Hybrid Modelling and Dynamical Analysis of Gene Regulatory Networks with Delays , 2007, Complexus.
[54] S. Waggoner,et al. HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL‐12 production , 2007, Journal of leukocyte biology.
[55] T. Mosmann,et al. IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.
[56] Martin Schwarick,et al. Snoopy - A Unifying Petri Net Tool , 2012, Petri Nets.
[57] S. Kamal,et al. Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C. , 2002, Gastroenterology.
[58] J. Gorham. Adaptive Immunity in the Liver , 2007 .
[59] U. Niazi,et al. Formal Modeling and Analysis of the MAL-Associated Biological Regulatory Network: Insight into Cerebral Malaria , 2012, PloS one.
[60] Adrien Richard,et al. Boolean Models of Biosurfactants Production in Pseudomonas fluorescens , 2012, PloS one.
[61] Judith Nedrow Production. JOURNAL OF VIROLOGY , 2011, Journal of Virology.
[62] R. Coffman,et al. Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.
[63] C. Egwuagu,et al. Interleukin 12 (IL-12) family cytokines: Role in immune pathogenesis and treatment of CNS autoimmune disease. , 2015, Cytokine.
[64] E. Wherry,et al. IL-10, T cell exhaustion and viral persistence. , 2007, Trends in microbiology.
[65] S. Waggoner,et al. NK cells and their ability to modulate T cells during virus infections. , 2014, Critical reviews in immunology.